Publication | Open Access
ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib
20
Citations
14
References
2019
Year
We firstly identified ROS1-ADGRG6 fusion variant in NSCLC by NGS, which should be considered in further ROS1 detecting assays.
| Year | Citations | |
|---|---|---|
Page 1
Page 1